Actively Recruiting
Efficacy of Lidocaine Local Anaesthetic Infiltration Compared With Placebo for Pudendal Neuralgia Treatment in a Randomized Trial
Led by Groupe Hospitalier Diaconesses Croix Saint-Simon · Updated on 2025-05-18
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Pudendal neuralgia (PN) is a chronic nerve compression syndrome that causes neuropathic pain similar to carpal tunnel syndrome. Treatments currently include medication, nerve infiltrations, and decompressive surgery. This research aims to compare the usual local anesthetic infiltration treatment under neurostimulation with a placebo, as no type of infiltration has been previously tested against placebo, despite the likelihood of a large placebo effect in this condition. The study focuses on patients who have not responded to standard drug treatments for neuropathic pain. Participants will receive either injections of lidocaine (6mL of 10 mg/mL) or saline solution at specific sites around the pudendal nerve (left and right ischioanal fossae and coccyx). The treatments are given under neurostimulation guidance. The study is randomized and single-blinded, comparing the effectiveness of lidocaine infiltration against placebo saline infiltration. During the study, participants will be monitored for pain relief using a visual analogue scale (VAS) at inclusion and one month after the first injection. The main outcome is the proportion of patients experiencing a pain reduction of at least 3 points on the VAS. The study involves regular assessments to evaluate treatment response and safety. Participation includes consent and ongoing evaluation for one month following treatment, with further follow-up as needed.
CONDITIONS
Brief Title
Evaluation of the Efficacy of Therapeutic Infiltrations of the Pudendal Nerve, Performed Under Neurostimulation on Pain, 1 Month After an Infiltration of Local Anaesthetic, in the Treatment of Pudendal Neuralgia.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient 18 years of age or older
- Provided informed consent to participate
- Affiliated with or beneficiary of a social security plan
- Diagnosed with pudendal neuralgia according to modified Nantes criteria
- Normal MRI or no pathology explaining the pain
- Failure of drug treatment defined as insufficient pain relief (VAS decrease less than 3) after trying at least one antiepileptic and one antidepressant drug at maximum tolerated doses
You will not qualify if you...
- Under legal protection measures
- Pregnant or breastfeeding women
- Current general or local infection (including fistulous or cutaneous anal margin suppuration)
- Known neurological conditions that explain the pain
- Psychiatric pathology requiring drug treatment
- Use of anticoagulants or bleeding disorders
- Hypersensitivity to lidocaine or local anesthetics
- History of recurrent porphyrias
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 month
Participants receive injections of either lidocaine or saline solution into specific sites to treat pudendal neuralgia.
1 treatment visit
Trial Site Locations
Total: 1 location
1
Hôpital Croix Saint-Simon
Paris, France, 75020
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here